Alcon Research, Ltd. et al. v. Apotex Inc. et al.
1:09-cv-00102; filed February 2, 2009 in the Southern District of Indiana

Infringement of U.S. Patent Nos. 5,641,805 (“Topical Ophthalmic Formulations for Treating Allergic Eye Diseases,” issued June 24, 1997), 6,995,186 (“Olopatadine Formulations for Topical Administration,” issued on February 7, 2006), and 7,402,609 (same title, issued July 22, 2008 ) following a Paragraph IV certification as part of Apotex’s filing of an ANDA to manufacture a generic version of Alcon’s Pataday® (olopatadine hydrochloride ophthalmic solution, used to treat ocular itching associated with allergic conjunctivitis).  View the complaint here.

Alcon Research, Ltd. et al. v. Sandoz Inc.
1:09-cv-00103; filed February 2, 2009 in the Southern District of Indiana

Infringement of U.S. Patent Nos. 5,641,805 (“Topical Ophthalmic Formulations for Treating Allergic Eye Diseases,” issued June 24, 1997) following a Paragraph IV certification as part of Sandoz’s filing of an ANDA to manufacture a generic version of Alcon’s Patanol® (olopatadine hydrochloride ophthalmic solution, used to treat ocular itching associated with allergic conjunctivitis).  View the complaint here.

Courtesy of Patent Docs.